Precision Oncology in Practice: How Theranostics Personalizes Treatment

In precision oncology, theranostics stands out as a transformative approach that tailors cancer treatment to the unique molecular profile of each patient. By integrating advanced diagnostic imaging with targeted therapy, theranostics ensures that treatments are customized to the unique characteristics of each patient's cancer, thereby optimizing efficacy and minimizing adverse effects.

By
May 11, 2025
4 min

Atlantic Health System

At a Glance

Category	Detail
Condition	Cancer
Key Mechanisms	Integration of advanced diagnostic imaging with targeted therapy to customize treatment based on molecular profiles.
Target Population	Patients with various cancers, particularly those with specific molecular targets.
Care Setting	Oncology clinics and specialized medical centers.

Key Highlights

Theranostics tailors cancer treatment to individual molecular profiles.
Utilizes PET-CT imaging for precise tumor localization and assessment.
Targets specific molecular markers with radioligand therapy.
Demonstrated effectiveness in prostate cancer, neuroendocrine tumors, and thyroid cancer.
Real-time monitoring of therapy effectiveness enhances treatment precision.

Guideline-Based Recommendations

Diagnosis

Evaluate presence of specific molecular targets using PET-CT imaging.

Management

Administer targeted radionuclide therapy based on molecular profiling.

Monitoring & Follow-up

Use imaging to assess treatment effectiveness after each therapy session.

Risks

Potential adverse effects from targeted therapies, though generally manageable.

Patient & Prescribing Data

Patients with prostate cancer, neuroendocrine tumors, and thyroid cancer.

Theranostics improves outcomes through targeted therapy and minimizes side effects.

Clinical Best Practices

Conduct thorough evaluations and discussions in tumor boards for patient selection.
Utilize dual-phase imaging and therapy for enhanced precision.
Ensure multidisciplinary collaboration among oncologists and radiation oncologists.